Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel ...
A pre-wedding video showing Pune realtor Ketan Agarwal joyfully celebrating with his fiancée Siya Goyal and her parents has ...
A road repair program designed for holistic city reconstruction was called into question by councilors Monday at a public works committee meeting in council chambers, 50 Town Square, Lima. If ...
Don't buy a "borrowed science" NAD supplement. Discover how Niagen Bioscience’s patented NR safely and efficiently boosts ...
The hottest new programming language is English. Andrej Karpathy, OpenAI co-founder and former Tesla AI director, said this ...
The Fund is beginning to generate tangible international outcomes, including awards, nominations and co-productions ...
Beauty's next frontier isn't a product, it's brain health, with science-backed rituals reshaping skincare and a wellness ...
Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...
Starting Wednesday, millions of Medicare-qualifying adults will have access to popular medications for weight loss at deep ...
MANILA, Philippines — The Quezon City government and pharmaceutical company Boehringer Ingelheim (Philippines) Inc. have ...
The Social Security Administration announced it will issue commemorative cards for newborns through the end of the year. Here is what they look like. (Adobe Stock) ...